We estimate and partition genetic variation for height, body mass index (BMI), von Willebrand factor and QT interval (QTi) using 586,898 SNPs genotyped on 11,586 unrelated individuals. We estimate that 45%, 17%, 25% and 21% of the variance in height, BMI, von Willebrand factor and QTi, respectively, can be explained by all autosomal SNPs and a further 0.5–1% can be explained by X chromosome SNPs. We show that the variance explained by each chromosome is proportional to its length, and that SNPs in or near genes explain more variation than SNPs between genes. We propose a new approach to estimate variation due to cryptic relatedness and population stratification. Our results provide further evidence that a substantial proportion of heritability is captured by common SNPs, that height, BMI and QTi are highly polygenic traits, and that the additive variation explained by a part of the genome is approximately proportional to the total length of DNA contained within genes therein.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. USA 106, 9362–9367 (2009).

  2. 2.

    et al. Finding the missing heritability of complex diseases. Nature 461, 747–753 (2009).

  3. 3.

    Genomewide association studies and assessment of the risk of disease. N. Engl. J. Med. 363, 166–176 (2010).

  4. 4.

    et al. Common SNPs explain a large proportion of the heritability for human height. Nat. Genet. 42, 565–569 (2010).

  5. 5.

    et al. Genome partitioning of genetic variation for height from 11,214 sibling pairs. Am. J. Hum. Genet. 81, 1104–1110 (2007).

  6. 6.

    et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 338, 464–468 (1991).

  7. 7.

    & The Nurses' Health Study: lifestyle and health among women. Nat. Rev. Cancer 5, 388–396 (2005).

  8. 8.

    et al. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium: design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ. Cardiovasc. Genet. 2, 73–80 (2009).

  9. 9.

    , , & GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011).

  10. 10.

    , & A commentary on 'common SNPs explain a large proportion of the heritability for human height' by Yang et al. (2010). Twin Res. Hum. Genet. 13, 517–524 (2010).

  11. 11.

    et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat. Genet. 41, 25–34 (2009).

  12. 12.

    et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat. Genet. 41, 18–24 (2009).

  13. 13.

    et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889–894 (2007).

  14. 14.

    et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 42, 937–948 (2010).

  15. 15.

    et al. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) consortium. Circulation 121, 1382–1392 (2010).

  16. 16.

    & Genetics of cardiac repolarization. Nat. Genet. 41, 388–389 (2009).

  17. 17.

    & The plasma concentration of factor viii in the normal population. II. The effects of age, sex and blood group. Br. J. Haematol. 10, 238–245 (1964).

  18. 18.

    , , & Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels. Arterioscler. Thromb. Vasc. Biol. 22, 335–341 (2002).

  19. 19.

    et al. A versatile gene-based test for genome-wide association studies. Am. J. Hum. Genet. 87, 139–145 (2010).

  20. 20.

    et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).

  21. 21.

    , , & New approaches to population stratification in genome-wide association studies. Nat. Rev. Genet. 11, 459–463 (2010).

  22. 22.

    The Mathematical Theory of Quantitative Genetics (Oxford University Press, New York, New York, USA, 1985).

  23. 23.

    et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467, 832–838 (2010).

  24. 24.

    et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748–752 (2009).

  25. 25.

    & Familial resemblance of body mass index and familial risk of high and low body mass index. A study of young men in Sweden. Int. J. Obes. Relat. Metab. Disord. 26, 1225–1231 (2002).

  26. 26.

    et al. Sex differences in heritability of BMI: a comparative study of results from twin studies in eight countries. Twin Res. 6, 409–421 (2003).

  27. 27.

    Genetic architecture of a complex trait and its implications for fitness and genome-wide association studies. Proc. Natl. Acad. Sci. USA 107, 1752–1756 (2010).

  28. 28.

    The 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467, 1061–1073 (2010).

  29. 29.

    , , , & Rare variants create synthetic genome-wide associations. PLoS Biol. 8, e1000294 (2010).

  30. 30.

    & Genetic heterogeneity in human disease. Cell 141, 210–217 (2010).

  31. 31.

    et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707–713 (2010).

  32. 32.

    , & Heritability in the genomics era-concepts and misconceptions. Nat. Rev. Genet. 9, 255–266 (2008).

  33. 33.

    et al. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am. J. Hum. Genet. 37, 89–101 (1985).

  34. 34.

    , , , & The genetics of haemostasis: a twin study. Lancet 357, 101–105 (2001).

  35. 35.

    et al. Heritability of QT interval: how much is explained by genes for resting heart rate? J. Cardiovasc. Electrophysiol. 19, 386–391 (2008).

  36. 36.

    , , & Heritability of ECG measurements in adult male twins. J. Electrocardiol. 30 Suppl, 64–68 (1998).

  37. 37.

    et al. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum. Mol. Genet. 19, 2706–2715 (2010).

  38. 38.

    et al. The gene, environment association studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions. Genet. Epidemiol. 34, 364–372 (2010).

  39. 39.

    et al. Quality control and quality assurance in genotypic data for genome-wide association studies. Genet. Epidemiol. 34, 591–602 (2010).

  40. 40.

    et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).

  41. 41.

    & Estimating the additive genetic effect of the X chromosome. Genet. Epidemiol. 29, 377–388 (2005).

  42. 42.

    et al. Mixed linear model approach adapted for genome-wide association studies. Nat. Genet. 42, 355–360 (2010).

  43. 43.

    et al. Variance component model to account for sample structure in genome-wide association studies. Nat. Genet. 42, 348–354 (2010).

Download references


Funding support for the Gene, Environment Association Studies (GENEVA) project has been provided through the US National Institutes of Health Genes, Environment and Health Initiative. For the ARIC project, support was from U01 HG 004402 (PI: E.A. Boerwinkle). For the NHS and HPFS support is from U01 HG 004399 and U01 HG 004728 (PIs: F.B. Hu and L.R. Pasquale). The genotyping for the ARIC, NHS and HPFS studies was performed at the Broad Institute of MIT and Harvard with funding support from U01 HG04424 (PI: S. Gabriel). The GENEVA Coordinating Center receives support from U01 HG 004446 (PI: B.S. Weir). Assistance with GENEVA data cleaning was provided by the National Center for Biotechnology Information. D. Crosslin and C. Laurie of the GENEVA project assisted in making the data available for analysis. A Physician Scientist Award from Research to Prevent Blindness in New York City also supports L.R.P. M.C.C. is a recipient of a Canadian Institutes of Health Research Fellowship. We acknowledge funding from the Australian National Health and Medical Research Council (NHMRC grants 389892 and 613672) and the Australian Research Council (ARC grants DP0770096 and DP1093900). We thank D. Posthuma for discussions and the referees for constructive comments.

Author information


  1. Queensland Statistical Genetics Laboratory, Queensland Institute of Medical Research, Brisbane, Australia.

    • Jian Yang
    •  & Peter M Visscher
  2. Office of Population Genomics, National Human Genome Research Institute (NHGRI), Bethesda, Maryland, USA.

    • Teri A Manolio
  3. Massachussetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA.

    • Louis R Pasquale
  4. Human Genetics Center and Division of Epidemiology, University of Texas Health Science Center, Houston, Texas, USA.

    • Eric Boerwinkle
  5. Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Bethesda, Maryland, USA.

    • Neil Caporaso
  6. Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

    • Julie M Cunningham
  7. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.

    • Mariza de Andrade
  8. Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.

    • Bjarke Feenstra
    •  & Mads Melbye
  9. Department of Human Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

    • Eleanor Feingold
  10. Division of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

    • M Geoffrey Hayes
  11. Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK.

    • William G Hill
  12. Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland, USA.

    • Maria Teresa Landi
  13. Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota, USA.

    • Alvaro Alonso
  14. Montréal Heart Institute, Université de Montréal, Montréal, Quebec, Canada.

    • Guillaume Lettre
  15. Human and Statistical Genetics Program, School of Medicine, Washington University, St. Louis, Missouri, USA.

    • Peng Lin
  16. Center for Inherited Disease Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

    • Hua Ling
    •  & Elizabeth Pugh
  17. Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

    • William Lowe
  18. Department of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

    • Rasika A Mathias
  19. Department of Nutrition, School of Public Health, Harvard University, Boston, Massachusetts, USA.

    • Marilyn C Cornelis
  20. Department of Biostatistics, University of Washington, Seattle, Washington, USA.

    • Bruce S Weir
  21. Department of Food and Agricultural Systems, University of Melbourne, Victoria, Australia.

    • Michael E Goddard
  22. Biosciences Research Division, Department of Primary Industries, Bundoora, Victoria, Australia.

    • Michael E Goddard


  1. Search for Jian Yang in:

  2. Search for Teri A Manolio in:

  3. Search for Louis R Pasquale in:

  4. Search for Eric Boerwinkle in:

  5. Search for Neil Caporaso in:

  6. Search for Julie M Cunningham in:

  7. Search for Mariza de Andrade in:

  8. Search for Bjarke Feenstra in:

  9. Search for Eleanor Feingold in:

  10. Search for M Geoffrey Hayes in:

  11. Search for William G Hill in:

  12. Search for Maria Teresa Landi in:

  13. Search for Alvaro Alonso in:

  14. Search for Guillaume Lettre in:

  15. Search for Peng Lin in:

  16. Search for Hua Ling in:

  17. Search for William Lowe in:

  18. Search for Rasika A Mathias in:

  19. Search for Mads Melbye in:

  20. Search for Elizabeth Pugh in:

  21. Search for Marilyn C Cornelis in:

  22. Search for Bruce S Weir in:

  23. Search for Michael E Goddard in:

  24. Search for Peter M Visscher in:


P.M.V., M.E.G., B.S.W. and T.A.M. designed the study. J.Y. performed all statistical analyses. J.Y. and P.M.V. wrote the first draft of the paper. L.R.P., E.B., N.C., J.M.C., M.d.A., B.F., E.F., M.G.H., W.G.H., M.T.L., A.A., G.L., P.L., H.L., W.L., R.A.M., M.M., E.P. and M.C.C. contributed by providing genotype and phenotype data, by giving advice on analyses and interpretation of results and/or by giving advice on the contents of the paper.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Peter M Visscher.

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Figures 1–9, Supplementary Tables 1–13 and Supplementary Note.

About this article

Publication history






Further reading